By aligning internal operations with outsourced processes and offering hands-on QA management support, we ensured a smooth, compliant, and practical implementation
About this Case Study
This case study highlights how Rephine supported a fast-growing biotech company specialising in novel cancer biotherapeutics as it prepared to enter non-clinical and clinical trial phases. The company, recently spun out from two institutions, needed to establish a fully GMP-compliant Quality Management System (QMS) to support its Investigational Medicinal Product (IMP) operations.
Facing challenges such as a lack of internal GMP knowledge and key roles being managed by external consultants, the company required a flexible yet robust QMS tailored to its structure and regulatory needs. Rephine delivered a scalable system, embedded QA oversight, and ensured alignment across internal teams and outsourced partners—achieving full GxP readiness and preparing the client for regulatory inspections.
Download the full case study now and discover how Rephine helped a biotech company achieve GMP compliance for their IMP operations.
Download the Case Study
View other our other resources and company news
Case Study GMP Consultancy for a New Manufacturing Plant
Article Why Quality Can No Longer Live in Silos
Article Why Most QMS Implementations Fail to Deliver Long-Term Value
Case Study Driving Global QMS Harmonisation for a Pharmaceutical Company
Guide How to Structure MDR Technical Documentation (Annex II & III). A Practical Compliance Guide
Blog IT Quality Assurance in Regulated Life Sciences: Key Insights
General Practical compliance and inspection readiness for UK pharmaceutical quality systems
Case Study Supporting Verification and Validation of a Medical Device Software (MDSW)
CSV 